ArticleCancer research communications2025

The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRASG12C Inhibitors in Preclinical Models.

Nathan M Jameson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.